Product Name

  • Name

    Dantrolene sodium salt

  • EINECS 238-706-8
  • CAS No. 14663-23-1
  • Article Data1
  • CAS DataBase
  • Density
  • Solubility
  • Melting Point
  • Formula C14H9N4O5Na
  • Boiling Point 85°C 4mm
  • Molecular Weight 336.239
  • Flash Point 283.1oC
  • Transport Information
  • Appearance COA
  • Safety 22-24/25
  • Risk Codes
  • Molecular Structure Molecular Structure of 14663-23-1 (Dantrolene sodium salt)
  • Hazard Symbols
  • Synonyms 2,4-Imidazolidinedione,1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-, sodium salt (9CI);Hydantoin, 1-[[5-(p-nitrophenyl)furfurylidene]amino]-, sodium salt (8CI);Dantrium;Dantrolene sodium;F 440;Sodium dantrolene;
  • PSA 127.05000
  • LogP 1.71410

Synthetic route

dantrolene
7261-97-4

dantrolene

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

Conditions
ConditionsYield
With sodium methylate In methanol at 20℃; for 3h;100%
5-(4-nitrophenyl)-2-furaldehyde
7147-77-5

5-(4-nitrophenyl)-2-furaldehyde

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / H2O; dimethylformamide
2: 100 percent / CH3ONa / methanol / 3 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

dantrolene
7261-97-4

dantrolene

Conditions
ConditionsYield
With acetic acid In N,N-dimethyl-formamide at 20℃;98%
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

tert-butyl 4-(2-iodoethyl)piperidine-1-carboxylate
89151-46-2

tert-butyl 4-(2-iodoethyl)piperidine-1-carboxylate

3-{[(1-tert-butoxycarbonyl)piperidin-4-yl]ethyl}-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

3-{[(1-tert-butoxycarbonyl)piperidin-4-yl]ethyl}-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃;96.4%
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

tert-butyl 4-(iodomethyl)piperidine-1-carboxylate
145508-94-7

tert-butyl 4-(iodomethyl)piperidine-1-carboxylate

3-{[(1-tert-butoxycarbonyl)piperidin-4-yl]methyl}-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

3-{[(1-tert-butoxycarbonyl)piperidin-4-yl]methyl}-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃;51.6%
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

di-tert-butyl chloromethyl phosphate
229625-50-7

di-tert-butyl chloromethyl phosphate

C23H29N4O9P

C23H29N4O9P

Conditions
ConditionsYield
With sodium iodide In N,N-dimethyl-formamide at 0 - 20℃; for 64h; Temperature;45%
N-[(1,1-dimethylethoxy)carbonyl]glycine chloromethyl ester
34573-36-9

N-[(1,1-dimethylethoxy)carbonyl]glycine chloromethyl ester

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C22H23N5O9

C22H23N5O9

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 110h;27%
tert-butyl chloromethyl butanedioate
432037-43-9

tert-butyl chloromethyl butanedioate

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C23H24N4O9

C23H24N4O9

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 20h;20%
1-benzyl-4-(2-hydroxyethyl)piperazine
3221-20-3

1-benzyl-4-(2-hydroxyethyl)piperazine

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

3-[(4-benzylpiperizin-1-yl)ethyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

3-[(4-benzylpiperizin-1-yl)ethyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: 1-benzyl-4-(2-hydroxyethyl)piperazine With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 20℃; for 0.333333h; Mitsunobu Displacement;
Stage #2: 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt In tetrahydrofuran at 60℃;
5.7%
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

2-bromoethanol
540-51-2

2-bromoethanol

(2-(2-hydroxyethoxy)-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)-1,5-dihydro-4H-imidazole-4-one)

(2-(2-hydroxyethoxy)-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)-1,5-dihydro-4H-imidazole-4-one)

Conditions
ConditionsYield
Stage #1: 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt With potassium carbonate In tetrahydrofuran; water for 0.5h;
Stage #2: 2-bromoethanol In tetrahydrofuran; water at 20℃; for 24h;
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

3-[(1-benzylpiperidin-4-yl)ethyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

3-[(1-benzylpiperidin-4-yl)ethyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide / 20 °C
2: hydrogenchloride / dichloromethane; 1,4-dioxane / 3 h / 20 °C
3: potassium carbonate / N,N-dimethyl-formamide / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C20H21N5O5

C20H21N5O5

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 20 °C
2: hydrogenchloride / dichloromethane; 1,4-dioxane / 3 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C21H23N5O5

C21H23N5O5

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 20 °C
2: hydrogenchloride / dichloromethane; 1,4-dioxane / 3 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

3-[(1-benzylpiperidin-4-yl)methyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

3-[(1-benzylpiperidin-4-yl)methyl]-1-{[5-(4-nitrophenyl)furfurylidene]amino}imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide / 20 °C
2: hydrogenchloride / dichloromethane; 1,4-dioxane / 3 h / 20 °C
3: potassium carbonate / N,N-dimethyl-formamide / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C15H12N4O6

C15H12N4O6

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C15H11ClN4O5

C15H11ClN4O5

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: phosphorus trichloride / N,N-dimethyl-formamide; acetone / 2.16 h / 0 - 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C21H21N5O8

C21H21N5O8

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 60 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C21H21N5O8*ClH

C21H21N5O8*ClH

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 60 °C
4: hydrogenchloride / water; 1,4-dioxane / 2 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C29H33N5O8Si

C29H33N5O8Si

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 16 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C23H19N5O8

C23H19N5O8

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 16 h / 20 °C
4: toluene-4-sulfonic acid / 1,4-dioxane; methanol / 16 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C27H23N5O11

C27H23N5O11

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 16 h / 20 °C
4: toluene-4-sulfonic acid / 1,4-dioxane; methanol / 16 h / 20 °C
5: toluene-4-sulfonic acid / 1,4-dioxane; m-xylene / 16 h / Molecular sieve; Reflux
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C27H23N5O11*C4H11NO3

C27H23N5O11*C4H11NO3

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: acetic acid / N,N-dimethyl-formamide / 20 °C
2: potassium carbonate / water / 24 h / 20 °C
3: triethylamine / N,N-dimethyl-formamide / 16 h / 20 °C
4: toluene-4-sulfonic acid / 1,4-dioxane; methanol / 16 h / 20 °C
5: toluene-4-sulfonic acid / 1,4-dioxane; m-xylene / 16 h / Molecular sieve; Reflux
6: water / 3 h / 20 °C
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

C15H11N4O9P(2-)*2Na(1+)

C15H11N4O9P(2-)*2Na(1+)

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium iodide / N,N-dimethyl-formamide / 64 h / 0 - 20 °C
2.1: trifluoroacetic acid / dichloromethane / 3 h / 20 °C
2.2: 20 °C / pH 8.5
View Scheme
1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt
14663-23-1

1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidine-dione sodium salt

dantrolene sodium trihemihydrate

dantrolene sodium trihemihydrate

Conditions
ConditionsYield
With water In methanol at 20 - 30℃; for 6h;

Dantrolene sodium salt Chemical Properties

Molecular Structure of Dantrolene sodium salt (CAS NO.14663-23-1):

IUPAC Name: Sodium  3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-5-oxo-4H-imidazol-2-olate
Molecular Formula: C14H9N4O5Na
Molecular Weight: 336.26g/mol
EINECS: 238-706-8
Boiling Point: 544.5 °C at 760 mmHg
Flash Point: 283.1 °C
Properties: solid
 Freely Rotating Bonds: 4 
Polar Surface Area: 124.22 Å2 
Polarizability: 10-24 cm3 
Enthalpy of Vaporization: 86.63 kJ/mol  
Vapour Pressure: 1.09E-12 mmHg at 25°C  
InChI
InChI=1/C14H10N4O5.Na/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22;/h1-7H,8H2,(H,16,19,20);/q;+1/p-1/b15-7+;
Smiles
N1(CC([NH-]C1=O)=O)\N=C\c1oc(cc1)c1ccc(cc1)[N+](=O)[O-].[Na+]
The chemical synonyms of Dantrolene sodium salt (CAS NO.14663-23-1) are Sodium dantrolene ; Dantrium ; Dantrolene na ; Dantrolene sodium salt ; 1-[[[5-(4-Nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolinedione sodium salt ; 1-[[[5-(4-Nitrophenyl)-2-furanyl]-methylene]imino]2,4-imidazolidinedione sodium salt ; 1-[(5-[p-Nitrophenyl]furfurylidene)-amino]hydantoin sodium salt ; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoinsodium .
Product categories: Pharmacetical ; API's ; InsP3/Ryanodine receptor .The molecular structure of Dantrium

Dantrolene sodium salt Toxicity Data With Reference

1.    

orl-hmn TDLo:320 mg/kg:BAH,GIT

    JAMAAP    JAMA, Journal of the American Medical Association. 231 (1975),662.
2.    

orl-wmn LDLo:600 mg/kg:GIT,SYS

    NYSJAM    New York State Journal of Medicine. 77 (1977),1759.
3.    

orl-rat LD50:7431 mg/kg

    IYKEDH    Iyakuhin Kenkyu. Study of Medical Supplies. 12 (1981),668.
4.    

ipr-rat LD50:413 mg/kg

    IYKEDH    Iyakuhin Kenkyu. Study of Medical Supplies. 12 (1981),668.
5.    

orl-mus LD50:1188 mg/kg

    JPMSAE    Journal of Pharmaceutical Sciences. 69 (1980),327.
6.    

ipr-mus LD50:534 mg/kg

    IYKEDH    Iyakuhin Kenkyu. Study of Medical Supplies. 12 (1981),668.

Dantrolene sodium salt Safety Profile

Moderately toxic by intraperitoneal and ingestion routes. Human systemic effects by ingestion: anorexia (human), hepatitis, nausea or vomiting, somnolence. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Na2O.
Safety Statements: 22-24/25
22:  Do not breathe dust 
24/25:  Avoid contact with skin and eyes
WGK Germany: 2
RTECS: MU3875000

Dantrolene sodium salt Specification

  In order to capture and identify key molecules that regulate the release of Ca(2+) from the sarcoplasmic reticulum (SR) of skeletal muscle, we designed specific photoaffinity probes based on the structural modification of dantrolene. Thus, GIF-0082 and GIF-0276 possessing azido- and trifluoromethyldiazirinyl-benzyl groups, respectively, at the hydantoin moiety were found to have a highly selective inhibitory effect on physiological Ca(2+) release without affecting Ca(2+)-induced Ca(2+) release (CICR). Successful realization of the sharp discrimination between PCR and CICR has led to the creation of [(125)I]GIF-0082 and [(125)I]GIF-0276, which were synthesized by substituting a stannyl group with (125)I in the corresponding phenylstannane precursors. It is a muscle relaxation drug for treatment of diseases associated with spastic paralysis.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View